Guardant Health, Inc. (GH)
91.84
-0.74
(-0.80%)
USD |
NASDAQ |
Mar 06, 12:06
Guardant Health Cash from Investing (Quarterly) : -905.07M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Illumina, Inc. | 108.00M |
| Quest Diagnostics, Inc. | -191.00M |
| Natera, Inc. | -71.59M |
| GeneDx Holdings Corp. | -11.07M |
| EXACT Sciences Corp. | 91.12M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.08M |
| Cash from Financing (Quarterly) | 719.74M |
| Free Cash Flow | -233.07M |
| Free Cash Flow Per Share (Quarterly) | -0.3259 |
| Free Cash Flow to Equity (Quarterly) | -425.70M |
| Free Cash Flow to Firm (Quarterly) | -40.77M |
| Free Cash Flow Yield | -2.02% |